Effect of once weekly dulaglutide by baseline beta‐cell function in people with type 2 diabetes in the AWARD programme

Glucagon‐like peptide‐1 receptor agonists lower blood glucose in type 2 diabetes (T2D) partially through glucose‐dependent stimulation of insulin secretion. The aim of this study was to investigate whether beta‐cell function (as measured by HOMA2‐%B) at baseline affects the glycaemic response to dul...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Diabetes Obes Metab
Auteurs principaux: Mathieu, Chantal, Del Prato, Stefano, Botros, Fady T., Thieu, Vivian T., Pavo, Imre, Jia, Nan, Haupt, Axel, Karanikas, Chrisanthi A., García‐Pérez, Luis‐Emilio
Format: Artigo
Langue:Inglês
Publié: Blackwell Publishing Ltd 2018
Sujets:
Brief Reports
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6055818/
https://ncbi.nlm.nih.gov/pubmed/29603872
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.13313
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires